STOCK TITAN

Amer Shared Hosp Stock Price, News & Analysis

AMS NYSE

Welcome to our dedicated page for Amer Shared Hosp news (Ticker: AMS), a resource for investors and traders seeking the latest updates and insights on Amer Shared Hosp stock.

American Shared Hospital Services (AMS: NYSE) delivers innovative financing solutions for advanced cancer treatment technologies, including Gamma Knife radiosurgery and proton beam therapy systems. This page provides investors and healthcare professionals with timely updates on AMS's strategic partnerships, financial performance, and technology deployments.

Access curated press releases and news articles covering AMS's domestic operations and international joint ventures in Latin America. Track developments in radiation therapy financing, equipment upgrades, and oncology service expansions. Our repository ensures stakeholders stay informed about AMS's role in making cutting-edge cancer treatment accessible worldwide.

Explore updates on key areas: quarterly earnings reports, collaborations with medical institutions, regulatory milestones, and new technology implementations like Elekta's Esprit systems. Bookmark this page for direct access to verified information supporting informed decisions about AMS's market position and healthcare impact.

Rhea-AI Summary

American Shared Hospital Services (NYSE American: AMS) will hold a quarterly conference call on August 12, 2022, to discuss its second quarter 2022 financial results. The results will be released after market close on August 11, 2022. Interested participants can join the call by dialing 1 (844) 413-3972 and accessing the webcast through the Company’s website at www.ashs.com. A replay will be available until August 19, 2022.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.35%
Tags
conferences earnings
-
Rhea-AI Summary

American Shared Hospital Services (AMS) reported a total revenue increase of 11.1% to $4,847,000 in Q1 2022, driven by a 33.2% increase in proton therapy revenue. Operating income surged to $600,000, a 567% increase, while net income reached $269,000 or $0.04 per share. Adjusted EBITDA grew by 20.1% to $1,922,000. AMS also announced a joint venture in Puebla, Mexico for a new radiation therapy facility. Cash reserves stood at $8.4 million with shareholders' equity at $24.72 million as of March 31, 2022.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4%
Tags
-
Rhea-AI Summary

American Shared Hospital Services (AMS) announced the hiring of Timothy J. Keel as Vice President of Sales and Marketing, effective May 3, 2022. Keel brings over 30 years of experience in healthcare finance, having previously worked at Dext Capital, BankAmerica, and Citibank. CEO Ray Stachowiak emphasized that Keel's expertise will enhance AMS's sales efforts. The company also mentioned a joint venture to install a linear accelerator at a radiation therapy center in Puebla, Mexico, marking its third international project.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.32%
Tags
none
Rhea-AI Summary

American Shared Hospital Services (NYSE American: AMS) will host a quarterly conference call on May 12, 2022, at 3:00 PM ET to discuss its first quarter 2022 financial results. A press release detailing these results will be issued premarket on the same day. Interested parties can participate by calling 1 (844) 413-3972 or accessing a simultaneous webcast on the company's website. AMS specializes in advanced radiation therapy technologies, including Gamma Knife radiosurgery and proton therapy, positioning itself as a leader in non-invasive tumor treatments.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.44%
Tags
conferences earnings
-
Rhea-AI Summary

American Shared Hospital Services (AMS) has scheduled its Annual Meeting of Shareholders for June 21, 2022, at 8:30 a.m. PST. Due to COVID-19, the meeting will be virtual-only, prioritizing shareholder safety. Shareholders eligible to vote will be determined as of April 22, 2022. AMS specializes in providing advanced technology solutions for stereotactic radiosurgery and radiation therapy, including Gamma Knife equipment for treating brain tumors and other conditions. The press release cautions about various risks affecting the company’s growth and financial health.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.33%
Tags
none
-
Rhea-AI Summary

American Shared Hospital Services (AMS) announces a joint venture to establish a cancer treatment facility in Puebla, Mexico, enhancing its international strategy. AMS will hold 85% ownership in the new company, responsible for upgrading a radiation therapy machine and providing advanced treatment options, including IMRT and radiosurgery. The facility aims to serve a region of over six million people, eliminating the need for long-distance travel for treatments. The facility is expected to be operational by early 2023, pending approvals.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.26%
Tags
none
Rhea-AI Summary

American Shared Hospital Services (AMS) reported a strong Q4 2021, with revenue reaching $4.69 million, a 1.8% increase from Q4 2020.

Proton therapy revenue rose 20.1% to $1.68 million, while Gamma Knife revenue fell 6.3% to $3 million. Operating income was $723,000, compared to an $8.54 million loss in Q4 2020. For the full year, revenue decreased 1.2% to $17.63 million, but operating income improved significantly from a loss of $9.46 million in 2020 to a profit of $1.35 million. Cash at year-end was $8.26 million, indicating strong liquidity.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.23%
Tags
-
Rhea-AI Summary

American Shared Hospital Services (NYSE American: AMS) will hold a quarterly conference call on March 24, 2022, at 4:00pm ET to discuss its Q4 and year-end 2021 financial results. The financial results press release will be available pre-market on the same day. AMS specializes in providing technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment. It is renowned for Gamma Knife radiosurgery systems and offers services in proton therapy and advanced imaging systems. For more details, visit ashs.com.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences earnings
-
Rhea-AI Summary

American Shared Hospital Services (AMS) reported preliminary Q4 2021 revenue of approximately $4.7 million, marking the highest quarterly revenue since the onset of the COVID-19 pandemic and stable compared to Q4 2020. For the full year, revenue totaled about $17.7 million, consistent with 2020 figures. The company noted improved operating income due to lower costs of revenue. Cash reserves increased to over $8 million, bolstered by a successful refinancing in Q2 2021. The final audited results will be released in late March 2022, accompanied by a quarterly conference call.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
15.17%
Tags
Rhea-AI Summary

American Shared Hospital Services (AMS) announced a restructuring of its Board of Directors, reducing membership to five. Effective December 28, 2021, new directors Kathleen Miles and Vicki L. Wilson were appointed, while Sandra A. J. Lawrence resigned. Founding Chairman and CEO Ernest A. Bates, M.D., and David L. Larson, M.D. also resigned from the Board but will continue as consultants. Miles brings over 20 years of public finance experience, while Wilson has extensive financial management experience in the healthcare sector. This transition could signal a shift in governance aimed at enhancing operational efficiency and strategic direction.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.85%
Tags
management

FAQ

What is the current stock price of Amer Shared Hosp (AMS)?

The current stock price of Amer Shared Hosp (AMS) is $2.58 as of August 13, 2025.

What is the market cap of Amer Shared Hosp (AMS)?

The market cap of Amer Shared Hosp (AMS) is approximately 16.0M.
Amer Shared Hosp

NYSE:AMS

AMS Rankings

AMS Stock Data

16.00M
3.13M
51.41%
13.91%
0.8%
Medical Care Facilities
Services-medical Laboratories
Link
United States
SAN FRANCISCO